StockNews.AI
AORT
StockNews.AI
4 hrs

Artivion to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

1. Artivion to participate in Morgan Stanley healthcare conference on September 10, 2025. 2. The company's fireside chat scheduled for 2:35 PM ET. 3. Artivion focuses on innovative solutions for aortic diseases. 4. The company markets products in over 100 countries. 5. Live webcast of the event will be available on their website.

10m saved
Insight
Article

FAQ

Why Bullish?

Participation in major conferences often boosts investor confidence and stock visibility. Previous similar events have positively impacted other healthcare firms, indicating potential upward movement.

How important is it?

Artivion's participation underscores its commitment to growth and innovation, appealing to investors. Increased visibility can lead to a favorable market response.

Why Short Term?

The conference is imminent, potentially generating quick market responses. Similar events previously led to immediate spikes in healthcare stocks.

Related Companies

ATLANTA, Sept. 5, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE:AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate at the upcoming Morgan Stanley 23rd Annual Global Healthcare Conference on Wednesday, September 10, 2025, at the Sheraton New York Times Square Hotel. The Company's fireside chat is scheduled to begin at 2:35 pm ET.

A live webcast can be accessed through Artivion's website, www.artivion.com, on the Investors page.  An archived copy of the webcast will be available for 90 days on the same website. 

About Artivion, Inc.

Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.Artivion.com.

Contacts:

Artivion



Gilmartin Group LLC

Lance A. Berry



Brian Johnston / Laine Morgan

Executive Vice President,



Phone: 332-895-3222

Chief Operating Officer &



investors@artivion.com

Chief Financial Officer





Phone: 770-419-3355











Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-to-participate-in-morgan-stanley-23rd-annual-global-healthcare-conference-302547997.html

SOURCE Artivion, Inc.

Related News